Special Considerations and Clinical Management of HIV in Patients With Substance Use Disorder

  • Author: Frederick L. Altice, MD (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 2/5/20 (What's New)

Summary

  • Pharmacotherapy for alcohol dependence combined with alcohol relapse prevention counseling is the most effective treatment for problem drinking and alcohol dependence in non–HIV-infected study populations[Garbutt 2009] but has not been studied in persons with HIV
  • 3 pharmacotherapies are FDA approved for the treatment of alcohol dependence: naltrexone, acamprosate, and disulfiram
    • NaltrexoneAcamprosate
      Disulfiram

      Action required

      Keywords: Initial Antiretroviral Therapy, IV Drug Use, Special Populations, Treatment Complications

      ©2020 Clinical Care Options, LLC. All Rights Reserved.

      The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.